Effect of bioactive additive mammoleptin on development of transplanted tumors in mice.
Bioactive additive mammoleptin used for the treatment of fibrocystic breast disease did not stimulate the growth of primary tumors and metastases in mice with transplanted tumors. Mammoleptin in high doses inhibited the growth of Ehrlich adenocarcinoma and metastatic spreading of solid tumors.
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.
E P
EP
Zueva
E M
EM
Naumova
B G
BG
Valentinov
E N
EN
Amosova
T G
TG
Razina
S G
SG
Krylova
N V
NV
Shilova
V E
VE
Gol'dberg
D000818:Animals; D001685:Biological Factors / Q000494:pharmacology*; D005260:Female; D005348:Fibrocystic Breast Disease / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary; D008516:Medicine, Chinese Traditional; D008546:Melanoma, Experimental / Q000188:drug therapy / Q000473:pathology / Q000556:secondary; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D010936:Plant Extracts / Q000494:pharmacology*
D001685:Biological Factors; D010936:Plant Extracts